Yuwan Lin

647 total citations
37 papers, 469 citations indexed

About

Yuwan Lin is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuwan Lin has authored 37 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 12 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuwan Lin's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Nuclear Receptors and Signaling (5 papers). Yuwan Lin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Nuclear Receptors and Signaling (5 papers). Yuwan Lin collaborates with scholars based in China, Taiwan and United States. Yuwan Lin's co-authors include Pingyi Xu, Wenyuan Guo, Xiaoqin Zhu, Miaomiao Zhou, Jiewen Qiu, Mingshu Mo, Zhiling Zhang, Liuyan Ding, Shuxuan Huang and Tsang‐Ming Ko and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Neurobiology of Aging.

In The Last Decade

Yuwan Lin

34 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwan Lin China 13 132 114 96 80 73 37 469
Jigar Modi United States 12 200 1.5× 98 0.9× 72 0.8× 106 1.3× 85 1.2× 18 537
Takashi Miyajima Japan 11 117 0.9× 176 1.5× 43 0.4× 33 0.4× 42 0.6× 22 432
Marianna D’Anca Italy 11 354 2.7× 135 1.2× 87 0.9× 81 1.0× 26 0.4× 18 640
Shadia E. Nada United States 11 225 1.7× 67 0.6× 31 0.3× 167 2.1× 40 0.5× 21 541
Yifeng Du China 15 212 1.6× 72 0.6× 149 1.6× 78 1.0× 61 0.8× 36 653
Xiao‐Liang Liu China 7 182 1.4× 54 0.5× 124 1.3× 47 0.6× 30 0.4× 10 405
Xuewu Liu China 14 175 1.3× 44 0.4× 237 2.5× 44 0.6× 104 1.4× 59 653
Isabella Peixoto de Barcelos United States 10 286 2.2× 89 0.8× 46 0.5× 51 0.6× 35 0.5× 20 552
Mahbuba Akther South Korea 10 343 2.6× 67 0.6× 109 1.1× 123 1.5× 62 0.8× 13 546
Huabao Liao China 11 196 1.5× 86 0.8× 56 0.6× 144 1.8× 47 0.6× 17 437

Countries citing papers authored by Yuwan Lin

Since Specialization
Citations

This map shows the geographic impact of Yuwan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwan Lin more than expected).

Fields of papers citing papers by Yuwan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwan Lin. The network helps show where Yuwan Lin may publish in the future.

Co-authorship network of co-authors of Yuwan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwan Lin. A scholar is included among the top collaborators of Yuwan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwan Lin. Yuwan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhiling, Jin Li, Si Zhu, et al.. (2025). Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease. Molecular Neurobiology. 62(10). 13500–13512. 1 indexed citations
2.
Hu, Huimin, et al.. (2025). Transaldolase 1 impacts Parkinson’s disease pathogenesis via metabolic reprogramming and autophagy-lysosomal pathway. Acta Neuropathologica Communications. 13(1). 223–223.
3.
Lin, Yuwan. (2025). The influence of network rumors on public health. Theoretical and Natural Science. 89(1). 125–130.
4.
Lin, Yuwan, Miaomiao Zhou, Wenyuan Guo, et al.. (2023). Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China. Neuroscience Letters. 813. 137426–137426. 3 indexed citations
5.
Lu, Yibo, Yiyang Zhou, Jing Guo, et al.. (2023). Integrated analysis of copy number variation-associated lncRNAs identifies candidates contributing to the etiologies of congenital kidney anomalies. Communications Biology. 6(1). 735–735. 1 indexed citations
6.
Lu, Yibo, Qing Fang, Ming Qi, et al.. (2023). Copy number variation-associated lncRNAs may contribute to the etiologies of congenital heart disease. Communications Biology. 6(1). 189–189. 5 indexed citations
7.
Lin, Yuwan, Zhiling Zhang, Yuting Tang, et al.. (2023). CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease. Neural Regeneration Research. 19(1). 196–204. 3 indexed citations
8.
Qiu, Jiewen, Shiyin Li, Yunxin Wang, et al.. (2023). Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease. Frontiers in Aging Neuroscience. 14. 1077738–1077738. 8 indexed citations
9.
Tao, Kai, Mingshu Mo, Wenyuan Guo, et al.. (2022). Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma. Neuroscience Bulletin. 38(6). 637–651. 5 indexed citations
10.
Li, Fei, Wenlong Zhang, Yuwan Lin, et al.. (2021). A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile. Frontiers in Cellular Neuroscience. 15. 780447–780447. 10 indexed citations
11.
Zhang, Wenlong, Yuwan Lin, Jiewen Qiu, et al.. (2021). A hydrogen sulfide donor suppresses pentylenetetrazol-induced seizures in rats via PKC signaling. European Journal of Pharmacology. 898. 173959–173959. 8 indexed citations
12.
Huang, Shuxuan, Yuwan Lin, Yànhuá Lǐ, et al.. (2021). Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model. Frontiers in Pharmacology. 11. 618787–618787. 58 indexed citations
13.
Lin, Yuwan, Miaomiao Zhou, Wei Dai, et al.. (2021). Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease. Frontiers in Aging Neuroscience. 13. 634213–634213. 17 indexed citations
14.
Zhou, Miaomiao, Yuwan Lin, Zhiling Zhang, et al.. (2021). Association of ADAM10 gene variants with sporadic Parkinson's disease in Chinese Han population. The Journal of Gene Medicine. 23(3). 7 indexed citations
15.
Lin, Yuwan, et al.. (2020). Inhibition of NMDA Receptors Downregulates Astrocytic AQP4 to Suppress Seizures. Cellular and Molecular Neurobiology. 40(8). 1283–1295. 13 indexed citations
16.
Zhang, Wenlong, Junwei Gong, Liuyan Ding, et al.. (2020). Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease. Cell Death and Disease. 11(10). 897–897. 18 indexed citations
17.
Guo, Wenyuan, Miaomiao Zhou, Jiewen Qiu, et al.. (2019). Association of LAG3 genetic variation with an increased risk of PD in Chinese female population. Journal of Neuroinflammation. 16(1). 270–270. 33 indexed citations
18.
Viray, Melissa, Megan G. Hofmeister, David Johnston, et al.. (2018). Public health investigation and response to a hepatitis A outbreak from imported scallops consumed raw—Hawaii, 2016. Epidemiology and Infection. 147. e28–e28. 26 indexed citations
19.
Lin, Yuwan, et al.. (2011). Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(1). 59–70. 2 indexed citations
20.
Ko, Tsang‐Ming, et al.. (1999). Molecular genetic study of Pompe disease in Chinese patients in Taiwan. Human Mutation. 13(5). 380–384. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026